Graham Capital Management, L.P. Atri Cure, Inc. Transaction History

Graham Capital Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$28.21 - $37.78 $443,094 - $593,410	-15,707 Reduced 58.68%	11,062 $336,000
Q4 2023 Feb 14, 2024	BUY	$32.99 - $43.25 $454,932 - $596,417	13,790 Added 106.25%	26,769 $955,000
Q3 2023 Nov 22, 2023	SELL	$41.12 - $57.73 $621,076 - $871,953	-15,104 Reduced 53.78%	12,979 $568,000
Q2 2023 Aug 14, 2023	SELL	$40.44 - $49.6 $106,074 - $130,100	-2,623 Reduced 8.54%	28,083 $1.39 Million
Q1 2023 May 15, 2023	SELL	$35.87 - $47.22 $76,223 - $100,342	-2,125 Reduced 6.47%	30,706 $1.27 Million
Q4 2022 Feb 14, 2023	BUY	$33.48 - $47.45 $1.1 Million - $1.56 Million	32,831 New	32,831 $1.46 Million

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.68B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.